Cycloartane glycosides from Astragalus stereocalyx Bornm

Area of Science:

• Natural Products Chemistry
• Pharmacology
• Medicinal Chemistry

Background:

• Astragalus species are a rich source of bioactive natural products.
• Cycloartane-type triterpene glycosides possess diverse biological activities.
• Understanding the chemical diversity and bioactivity of Astragalus stereocalyx is ongoing.

Purpose of the Study:

• To isolate and characterize novel cycloartane-type triterpene glycosides from Astragalus stereocalyx.
• To evaluate the cytotoxic activity of the isolated compounds against various cancer cell lines.
• To identify potential leads for anticancer drug development.

Main Methods:

• Isolation of compounds using chromatographic techniques.
• Structure elucidation through comprehensive spectroscopic analyses (1D/2D-NMR, ESIMS, HRMS).
• In vitro cytotoxic activity assay against human cancer cell lines (e.g., Hela).

Main Results:

• Six new cycloartane-type triterpene glycosides were isolated, alongside six known compounds.
• Three novel compounds feature an unusual hydroxyl group at position 20 of the aglycon.
• One isolated compound demonstrated significant cytotoxic activity against Hela cells with an IC(50) of 10 μM.

Conclusions:

• The study expands the known chemical diversity of cycloartane-type glycosides from Astragalus stereocalyx.
• The identified cytotoxic activity suggests potential therapeutic applications for these natural products.
• Further investigation into the mechanism of action and structure-activity relationships is warranted.